Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brandon

Showing results (391-400 of 431) with videos related to

Pageof 44
Sort By:
Journal of Medicinal Chemistry|October 13, 2011
Highly potent, selective, and orally active phosphodiesterase 10A inhibitorsMichael S Malamas, Yike Ni, James Erdei, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2017
Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amidesJames C Tarr, Michael R Wood, Meredith J Noetzel, et al.
Plos One|June 24, 2015
Effects of a Balanced Translocation between Chromosomes 1 and 11 Disrupting the DISC1 Locus on White Matter IntegrityHeather C Whalley, Rali Dimitrova, Emma Sprooten, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Novel triazines as potent and selective phosphodiesterase 10A inhibitorsMichael S Malamas, Hans Stange, Rudolf Schindler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2019
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical TrialsPedro Cahn, Juan Sierra Madero, José R Arribas, et al.
Nature Neuroscience|July 28, 2018
Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesisAndrew E Jaffe, Richard E Straub, Joo Heon Shin, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2018
Corrigendum to "Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179-5184]James C Tarr, Michael R Wood, Meredith J Noetzel, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2017
Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amidesJames C Tarr, Michael R Wood, Meredith J Noetzel, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
Science (New York, N.Y.)|November 19, 2005
DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signalingJ Kirsty Millar, Benjamin S Pickard, Shaun Mackie, et al.
Pageof 44

Showing results (391-400 of 431) with videos related to

Sort By:
Pageof 44
Journal of Medicinal Chemistry|October 13, 2011
Highly potent, selective, and orally active phosphodiesterase 10A inhibitorsMichael S Malamas, Yike Ni, James Erdei, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2017
Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amidesJames C Tarr, Michael R Wood, Meredith J Noetzel, et al.
Plos One|June 24, 2015
Effects of a Balanced Translocation between Chromosomes 1 and 11 Disrupting the DISC1 Locus on White Matter IntegrityHeather C Whalley, Rali Dimitrova, Emma Sprooten, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Novel triazines as potent and selective phosphodiesterase 10A inhibitorsMichael S Malamas, Hans Stange, Rudolf Schindler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2019
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical TrialsPedro Cahn, Juan Sierra Madero, José R Arribas, et al.
Nature Neuroscience|July 28, 2018
Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesisAndrew E Jaffe, Richard E Straub, Joo Heon Shin, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2018
Corrigendum to "Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179-5184]James C Tarr, Michael R Wood, Meredith J Noetzel, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2017
Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amidesJames C Tarr, Michael R Wood, Meredith J Noetzel, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
Science (New York, N.Y.)|November 19, 2005
DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signalingJ Kirsty Millar, Benjamin S Pickard, Shaun Mackie, et al.
Pageof 44